Zobrazeno 1 - 10 of 70 pro vyhledávání: '"Lars Korsholm"'
1
Illustrative Cases from the Pathfinder Clinical Trials of Patients with Hemophilia A Treated with Turoctocog Alfa Pegol (N8-GP)
Autor: Manuel Carcao, Kingsley Hampton, Lars Korsholm, Robert Klamroth, Sonata Saulyte Trakymienė
Publikováno v: Patient preference and adherence
Patient preference and adherence, Auckland : Dove Medical Press Ltd, 2021, vol. 15, p. 2443-2454
Patient Preference and Adherence, Vol Volume 15, Pp 2443-2454 (2021)
Purpose To illustrate the benefits of the extended half-life (EHL) recombinant factor VIII product N8-GP (Esperoct®, turoctocog alfa pegol) by describing individual cases of patients with severe hemophilia A treated with N8-GP in the pathfinder clin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3110aed353e927dca096ac93b701e424
http://europepmc.org/articles/PMC8575374
Zobrazit plný text záznamu
2
Safety and efficacy of turoctocog alfa in the prevention and treatment of bleeds in previously untreated paediatric patients with severe haemophilia A: Results from the guardian 4 multinational clinical trial
Autor: Kaan Kavakli, Meriem Belhani, Kirsten Reichwald, Lars Korsholm, Runhui Wu, Hassan M. Yaish, Irina Matytsina, Víctor Jiménez-Yuste, Claire S. Philipp, Tadashi Matsushita
Publikováno v: Haemophilia
Biblos-e Archivo. Repositorio Institucional de la UAM
Universitat Jaume I
Biblos-e Archivo: Repositorio Institucional de la UAM
Universidad Autónoma de Madrid
Introduction Turoctocog alfa is a recombinant, B domain-truncated factor VIII (FVIII) approved for patients with haemophilia A. Aim To evaluate the safety and efficacy of turoctocog alfa in previously untreated patients (PUPs) with severe haemophilia
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbbd9ca996d4fbcd2e1bccf43200c136
http://europepmc.org/articles/PMC7028046
Zobrazit plný text záznamu
3
Physical activity is prospectively associated with spinal pain in children (CHAMPS Study-DK)
Autor: Claudia Franz, Niels Møller, Lars Korsholm, Jeffrey J. Hebert, Eva Jespersen, Niels Wedderkopp
Publikováno v: Scientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
Franz, C, Møller, N C, Korsholm, L, Jespersen, E, Hebert, J J & Wedderkopp, N 2017, ' Physical activity is prospectively associated with spinal pain in children (CHAMPS Study-DK) ', Scientific Reports, vol. 7, 11598 . https://doi.org/10.1038/s41598-017-11762-4
Scientific Reports
AbstarctSpinal pain and physical inactivity are critical public health issues. We investigated the prospective associations of physical activity intensity with spinal pain in children. Physical activity was quantified with accelerometry in a cohort o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43f56058d3a2f3be5d968514e86b5bb4
http://link.springer.com/article/10.1038/s41598-017-11762-4
Zobrazit plný text záznamu
4
Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial
Autor: Margareth C. Ozelo, Irina Matytsina, Kaan Kavakli, Elena Santagostino, Steven R. Lentz, Andreas Tiede, Silva Zupančić Šalek, Lars Korsholm, Dragana Janic, T. Suzuki, Predrag Miljic, Johannes Oldenburg
Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia. 24(6)
WOS: 000451454400001
PubMed ID: 30402994
Introduction Turoctocog alfa is a recombinant factor VIII (FVIII) molecule, approved for treatment and prophylaxis of bleeding in patients with haemophilia A. In the guardian 1 (adolescents/adults) a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d657bb1c281f49eae6960286c1c4f17b
https://pubmed.ncbi.nlm.nih.gov/30402994
Zobrazit plný text záznamu
5
Individual courses of low back pain in adult Danes: a cohort study with 4-year and 8-year follow-up
Autor: Lars Korsholm, Lise Hestbæk, Per Kjaer, Tom Bendix, Charlotte Leboeuf-Yde
Publikováno v: Kjær, P, Korsholm, L, Leboeuf-Yde, C, Hestbæk, L & Bendix, T 2017, ' Individual courses of low back pain in adult Danes : a cohort study with 4-year and 8-year follow-up ', BMC Musculoskeletal Disorders, vol. 18, 28 . https://doi.org/10.1186/s12891-016-1377-0
BMC Musculoskeletal Disorders
Kjaer, P, Korsholm, L, Leboeuf-Yde, C, Hestbaek, L & Bendix, T 2017, ' Individual courses of low back pain in adult Danes : a cohort study with 4-year and 8-year follow-up ', BMC Musculoskeletal Disorders, vol. 18, 28 . https://doi.org/10.1186/s12891-016-1377-0
BACKGROUND: Few longitudinal studies have described the variation in LBP and its impact over time at an individual level. The aims of this study were to: 1) determine the prevalence of LBP in three surveys over a 9-year period in the Danish general p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16f7292159d5aa9ed82348df817c8871
https://doi.org/10.1186/s12891-016-1377-0
Zobrazit plný text záznamu
6
Interpretation of Subgroup Effects in Published Trials
Autor: Peter Kent, Lars Korsholm, Per Kjaer, Mark J. Hancock
Publikováno v: Hancock, M J, Kjær, P, Korsholm, L & Kent, P 2013, ' Interpretation of Subgroup Effects in Published Trials ', Physical Therapy Products, vol. 93, no. 6, pp. 852-859 . https://doi.org/10.2522/ptj.20120296
With the rapidly expanding number of studies reporting on treatment subgroups come new challenges in analyzing and interpreting this sometimes complex area of the literature. This article discusses 3 important issues regarding the analysis and interp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e529e964682feebbd9649c59ce999105
https://doi.org/10.2522/ptj.20120296
Zobrazit plný text záznamu
7
Medical school dropout - testing at admission versus selection by highest grades as predictors
Autor: Berit Eika, Lars Korsholm, Jan Hartvigsen, Birgitta Wallstedt, Lotte Dyhrberg O'Neill
Publikováno v: Medical Education. 45:1111-1120
Medical Education 2011: 45: 1111–1120 Context Very few studies have reported on the effect of admission tests on medical school dropout. The main aim of this study was to evaluate the predictive validity of non-grade-based admission testing versus
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7423889c2bed89cc6a1c7093858bef9e
https://doi.org/10.1111/j.1365-2923.2011.04057.x
Zobrazit plný text záznamu
8
Counter-regulatory hormone responses to spontaneous hypoglycaemia during treatment with insulin Aspart or human soluble insulin: a double-blinded randomized cross-over study
Autor: Henning Beck-Nielsen, Allan Flyvbjerg, Jan Frystyk, I Brock Jacobsen, Lars Korsholm, Birgitte F. Vind, Jan Erik Henriksen, Jens J. Holst
Publikováno v: Acta Physiologica. 202:337-347
Aims: To compare insulin Aspart and human insulin with respect to glycaemic control, hypoglycaemic frequency and counter-regulatory responses to spontaneous hypoglycaemia. Methods: Glycaemic control, hypoglycaemic frequency, p-insulin concentrations,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::127bcff72f8d2f4a141a62d977194118
https://doi.org/10.1111/j.1748-1716.2011.02307.x
Zobrazit plný text záznamu
9
A New Dosing Model Based on Body Mass Index to Guide Factor VIII Dosing in Patients with Hemophilia A
Autor: Paula Persson, Irina Matytsina, Predrag Miljic, Toshko Lissitchkov, Andreas Tiede, Georg Goldmann, Lars Korsholm
Publikováno v: Blood. 132:2491-2491
See attached image file Disclosures Tiede: Alnylam, Bayer, Biogen Idec, Biotest, Bristol-Myers-Squibb, Boehringer Ingelheim, CSL Behring, Leo Pharma, Novo Nordisk, Octapharma, Pfizer, Roche, Shire, and SOBI: Consultancy; Alnylam, Bayer, Biogen Idec,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::57c2c6fb3a76fa4605b61ec99ce539ca
https://doi.org/10.1182/blood-2018-99-111269
Zobrazit plný text záznamu
10
What is an acceptable outcome of treatment before it begins? Methodological considerations and implications for patients with chronic low back pain
Autor: Niels Grunnet-Nilsson, Jan Hartvigsen, Henrik Hein Lauridsen, Claus Manniche, Lars Korsholm
Publikováno v: Lauridsen, H, Manniche, C, Korsholm, L, Grunnet-Nilsson, N & Hartvigsen, J 2009, ' What is an acceptable outcome of treatment before it begins? Methodological considerations and implications for patients with chronic low back pain ', European Spine Journal, vol. 18, no. 12, pp. 1858-1866 . https://doi.org/10.1007/s00586-009-1070-1
Udgivelsesdato: 2009-Jun-23 Understanding changes in patient-reported outcomes is indispensable for interpretation of results from clinical studies. As a consequence the term "minimal clinically important difference" (MCID) was coined in the late 198
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc46ca8b36cec2d16d35e4ce8233e291
https://doi.org/10.1007/s00586-009-1070-1
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje